Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
6201
6202
6203
6204
6205
6206
6207
6208
6209
6210
6211
6212
6213
6214
6215
6216
6217
6218
6219
6220
6221
6222
6223
6224
6225
6226
6227
6228
6229
6230
6231
6232
6233
6234
6235
6236
6237
6238
6239
6240
6241
6242
6243
6244
6245
6246
6247
6248
6249
6250
6251
6252
6253
6254
6255
6256
6257
6258
6259
6260
6261
6262
6263
6264
6265
6266
6267
6268
6269
6270
6271
6272
6273
6274
6275
6276
6277
6278
6279
6280
6281
6282
6283
6284
6285
6286
6287
6288
6289
6290
6291
6292
6293
6294
6295
6296
6297
6298
6299
6300
6301
6302
6303
6304
6305
6306
6307
6308
6309
6310
6311
6312
6313
6314
6315
6316
6317
6318
6319
6320
6321
6322
6323
6324
6325
6326
6327
6328
6329
6330
6331
6332
6333
6334
6335
6336
6337
6338
6339
6340
6341
6342
6343
6344
6345
6346
6347
6348
6349
6350
6351
6352
6353
6354
6355
6356
6357
6358
6359
6360
6361
6362
6363
6364
6365
6366
6367
6368
6369
6370
6371
6372
6373
6374
6375
6376
6377
6378
6379
6380
6381
6382
6383
6384
6385
6386
6387
6388
6389
6390
6391
6392
6393
6394
6395
6396
6397
6398
6399
6400
| UnnamedSample_HQ_transcript/30016|m.9486 | UnnamedSample_HQ_transcript/30016 | Coverage 0.906 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/30016|m.9486 | UnnamedSample_HQ_transcript/30016 | Coverage 0.906 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/30016|m.9486 | UnnamedSample_HQ_transcript/30016 | Coverage 0.906 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7437|m.2999 | UnnamedSample_HQ_transcript/7437 | Coverage 0.968 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25928|m.8457 | UnnamedSample_HQ_transcript/25928 | Coverage 0.874 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6847|m.2811 | UnnamedSample_HQ_transcript/6847 | Coverage 0.946 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8308|m.3293 | UnnamedSample_HQ_transcript/8308 | Coverage 0.911 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4776|m.2103 | UnnamedSample_HQ_transcript/4776 | Coverage 0.918 too low. | a467d2e82ba5af34bc86a0908224b721 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/74391|m.18722 | UnnamedSample_HQ_transcript/74391 | Coverage 0.685 too low. | d6d00a3ece8a6600bcd410c593102e97 | 459 | Pfam | PF00135 | Carboxylesterase family | 10 | 447 | 9.8E-67 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/9963|m.3817 | UnnamedSample_HQ_transcript/9963 | Coverage 0.394 too low. | cff66b43810b2cdcf695e2e389ea0f33 | 944 | Pfam | PF00069 | Protein kinase domain | 489 | 743 | 5.6E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/9963|m.3817 | UnnamedSample_HQ_transcript/9963 | Coverage 0.394 too low. | cff66b43810b2cdcf695e2e389ea0f33 | 944 | Pfam | PF06479 | Ribonuclease 2-5A | 750 | 872 | 2.7E-41 | T | 22-09-2020 | IPR010513 | KEN domain |
| UnnamedSample_HQ_transcript/80989|m.19879 | UnnamedSample_HQ_transcript/80989 | Coverage 0.773 too low. | e21b207512e5cbe21ecd0db72c732832 | 427 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 37 | 118 | 1.6E-16 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/40265|m.11900 | UnnamedSample_HQ_transcript/40265 | Coverage 0.839 too low. | 0a134315b32df0020db9e73ee4b6db03 | 337 | Pfam | PF00501 | AMP-binding enzyme | 64 | 333 | 4.7E-57 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF00041 | Fibronectin type III domain | 661 | 748 | 7.1E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF00041 | Fibronectin type III domain | 216 | 318 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF00041 | Fibronectin type III domain | 770 | 849 | 1.9E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF00041 | Fibronectin type III domain | 452 | 531 | 4.0E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF01682 | DB module | 351 | 442 | 4.6E-14 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF01682 | DB module | 1063 | 1149 | 8.0E-15 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF01682 | DB module | 560 | 651 | 8.8E-17 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF01682 | DB module | 114 | 207 | 1.3E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6820|m.2805 | UnnamedSample_HQ_transcript/6820 | Coverage 0.952 too low. | d831de6dec1d0cb1cee86ea37d88b3c8 | 1213 | Pfam | PF07679 | Immunoglobulin I-set domain | 963 | 1051 | 1.3E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8814|m.3451 | UnnamedSample_HQ_transcript/8814 | Coverage 0.895 too low. | 17d282d211b2baea5b2fb39b33e3a332 | 648 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 138 | 217 | 5.0E-13 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/8814|m.3451 | UnnamedSample_HQ_transcript/8814 | Coverage 0.895 too low. | 17d282d211b2baea5b2fb39b33e3a332 | 648 | Pfam | PF07679 | Immunoglobulin I-set domain | 339 | 405 | 2.0E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8814|m.3451 | UnnamedSample_HQ_transcript/8814 | Coverage 0.895 too low. | 17d282d211b2baea5b2fb39b33e3a332 | 648 | Pfam | PF13927 | Immunoglobulin domain | 244 | 304 | 3.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 125 | 160 | 1.1E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 165 | 199 | 2.9E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 209 | 247 | 3.1E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 81 | 116 | 6.7E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 506 | 541 | 8.9E-5 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/45011|m.12915 | UnnamedSample_HQ_transcript/45011 | Identity 0.799 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 463 | 498 | 1.9E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 125 | 160 | 1.1E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 165 | 199 | 2.9E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 209 | 247 | 3.1E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 81 | 116 | 6.7E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 506 | 541 | 8.9E-5 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/38603|m.11530 | UnnamedSample_HQ_transcript/38603 | Identity 0.814 too low. | c565302d6bff9da9373f8fbe393de131 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 463 | 498 | 1.9E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/75120|m.18866 | UnnamedSample_HQ_transcript/75120 | Coverage 0.215 too low. | ba841422c23a21bb0e250236eded8593 | 454 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/3388|m.1587 | UnnamedSample_HQ_transcript/3388 | Coverage 0.925 too low. | e6278b06a8434083fb9dd85eeb686c9f | 1034 | Pfam | PF10541 | Nuclear envelope localisation domain | 981 | 1034 | 1.8E-17 | T | 22-09-2020 | IPR012315 | KASH domain |
| UnnamedSample_HQ_transcript/70018|m.17934 | UnnamedSample_HQ_transcript/70018 | Coverage 0.229 too low. | 36fef6ce43f67e7df7b4a4286110b596 | 563 | Pfam | PF00069 | Protein kinase domain | 194 | 457 | 4.5E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/70018|m.17934 | UnnamedSample_HQ_transcript/70018 | Coverage 0.229 too low. | 36fef6ce43f67e7df7b4a4286110b596 | 563 | Pfam | PF00615 | Regulator of G protein signaling domain | 58 | 176 | 1.3E-11 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/43811|m.12668 | UnnamedSample_HQ_transcript/43811 | Coverage 0.972 too low. | 8194a27e627b29c3d282485e59865c39 | 444 | Pfam | PF12026 | Crk-Associated Substrate C-terminal domain | 253 | 437 | 3.1E-53 | T | 22-09-2020 | IPR021901 | CAS family, C-terminal |
| UnnamedSample_HQ_transcript/43811|m.12668 | UnnamedSample_HQ_transcript/43811 | Coverage 0.972 too low. | 8194a27e627b29c3d282485e59865c39 | 444 | Pfam | PF08824 | Serine rich protein interaction domain | 76 | 241 | 8.1E-48 | T | 22-09-2020 | IPR014928 | Serine rich protein interaction domain |
| UnnamedSample_HQ_transcript/51226|m.14287 | UnnamedSample_HQ_transcript/51226 | Coverage 0.965 too low. | 8194a27e627b29c3d282485e59865c39 | 444 | Pfam | PF12026 | Crk-Associated Substrate C-terminal domain | 253 | 437 | 3.1E-53 | T | 22-09-2020 | IPR021901 | CAS family, C-terminal |
| UnnamedSample_HQ_transcript/51226|m.14287 | UnnamedSample_HQ_transcript/51226 | Coverage 0.965 too low. | 8194a27e627b29c3d282485e59865c39 | 444 | Pfam | PF08824 | Serine rich protein interaction domain | 76 | 241 | 8.1E-48 | T | 22-09-2020 | IPR014928 | Serine rich protein interaction domain |
| UnnamedSample_HQ_transcript/33687|m.10388 | UnnamedSample_HQ_transcript/33687 | Coverage 0.880 too low. | 52d8f9785ff2c0b83c5a7f126c3e60b0 | 701 | Pfam | PF04437 | RINT-1 / TIP-1 family | 246 | 666 | 2.3E-97 | T | 22-09-2020 | IPR007528 | RINT-1/Tip20 |
| UnnamedSample_HQ_transcript/112176|m.24099 | UnnamedSample_HQ_transcript/112176 | Coverage 0.990 too low. | cf65b875f51b73fe02754dce60076b53 | 261 | Pfam | PF04258 | Signal peptide peptidase | 42 | 259 | 5.1E-66 | T | 22-09-2020 | IPR007369 | Peptidase A22B, signal peptide peptidase |
| UnnamedSample_HQ_transcript/6846|m.2810 | UnnamedSample_HQ_transcript/6846 | Coverage 0.757 too low. | ed5740e5bb0a05ee3cd0a53a3d08c9a3 | 757 | Pfam | PF00620 | RhoGAP domain | 588 | 724 | 6.3E-30 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/6846|m.2810 | UnnamedSample_HQ_transcript/6846 | Coverage 0.757 too low. | ed5740e5bb0a05ee3cd0a53a3d08c9a3 | 757 | Pfam | PF00784 | MyTH4 domain | 433 | 551 | 1.3E-26 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/60920|m.16241 | UnnamedSample_HQ_transcript/60920 | Coverage 0.802 too low. | 0aafea4c1278251d385e68aa1e2c5f28 | 549 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 31 | 535 | 5.3E-155 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/38858|m.11590 | UnnamedSample_HQ_transcript/38858 | Coverage 0.846 too low. | 0aafea4c1278251d385e68aa1e2c5f28 | 549 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 31 | 535 | 5.3E-155 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/43626|m.12621 | UnnamedSample_HQ_transcript/43626 | Coverage 0.837 too low. | 0aafea4c1278251d385e68aa1e2c5f28 | 549 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 31 | 535 | 5.3E-155 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/50218|m.14064 | UnnamedSample_HQ_transcript/50218 | Coverage 0.817 too low. | 0aafea4c1278251d385e68aa1e2c5f28 | 549 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 31 | 535 | 5.3E-155 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/51459|m.14344 | UnnamedSample_HQ_transcript/51459 | Coverage 0.685 too low. | 8e31c7c51fd16c8ec3956d53104a241c | 569 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 88 | 123 | 1.1E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 1 | 132 | 1.6E-37 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 197 | 252 | 5.2E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 320 | 368 | 3.8E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 836 | 885 | 8.1E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 260 | 317 | 2.0E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 987 | 1029 | 1.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 777 | 833 | 2.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 371 | 409 | 1.3E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 888 | 936 | 3.6E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 939 | 981 | 5.5E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 134 | 184 | 2.8E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 681 | 729 | 1.2E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3568|m.1640 | UnnamedSample_HQ_transcript/3568 | Coverage 0.932 too low. | a7709ebbae763419dff516ce207ce23a | 1571 | Pfam | PF00053 | Laminin EGF domain | 633 | 678 | 3.7E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/9489|m.3667 | UnnamedSample_HQ_transcript/9489 | Coverage 0.145 too low. | ac745f23a531905ac82330aca82ea735 | 1160 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 105 | 189 | 8.9E-6 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/59779|m.16014 | UnnamedSample_HQ_transcript/59779 | Coverage 0.608 too low. | 1439887594d34453ab62eec569d7f518 | 373 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 65 | 330 | 2.8E-48 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/14564|m.5281 | UnnamedSample_HQ_transcript/14564 | Coverage 0.051 too low. | 9e47edb63a1e06657a7c70c102a98619 | 151 | Pfam | PF07855 | Autophagy-related protein 101 | 9 | 139 | 2.8E-30 | T | 22-09-2020 | IPR012445 | Autophagy-related protein 101 |
| UnnamedSample_HQ_transcript/107347|m.23504 | UnnamedSample_HQ_transcript/107347 | Coverage 0.574 too low. | cf5493a932391073e1c35637f5f7da1c | 157 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 28 | 145 | 2.8E-32 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/102027|m.22870 | UnnamedSample_HQ_transcript/102027 | Coverage 0.510 too low. | cf5493a932391073e1c35637f5f7da1c | 157 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 28 | 145 | 2.8E-32 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/16218|m.5773 | UnnamedSample_HQ_transcript/16218 | Coverage 0.690 too low. | 70c97cfcde2490f8fb3c074923e7cad6 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 2.3E-67 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/16218|m.5773 | UnnamedSample_HQ_transcript/16218 | Coverage 0.690 too low. | 70c97cfcde2490f8fb3c074923e7cad6 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/16218|m.5773 | UnnamedSample_HQ_transcript/16218 | Coverage 0.690 too low. | 70c97cfcde2490f8fb3c074923e7cad6 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/16218|m.5773 | UnnamedSample_HQ_transcript/16218 | Coverage 0.690 too low. | 70c97cfcde2490f8fb3c074923e7cad6 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/7435|m.2998 | UnnamedSample_HQ_transcript/7435 | Coverage 0.984 too low. | cb5d1117fbb7a5e9eb093e3c9587a981 | 695 | Pfam | PF16294 | RNSP1-SAP18 binding (RSB) motif | 572 | 659 | 3.1E-21 | T | 22-09-2020 | IPR032552 | Acin1, RNSP1-SAP18 binding (RSB) motif |
| UnnamedSample_HQ_transcript/64310|m.16911 | UnnamedSample_HQ_transcript/64310 | Unmapped. | e765ac79f29d7de5beb7b935a026c1d1 | 542 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 340 | 524 | 1.4E-40 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/64310|m.16911 | UnnamedSample_HQ_transcript/64310 | Unmapped. | e765ac79f29d7de5beb7b935a026c1d1 | 542 | Pfam | PF02403 | Seryl-tRNA synthetase N-terminal domain | 3 | 94 | 3.1E-18 | T | 22-09-2020 | IPR015866 | Serine-tRNA synthetase, type1, N-terminal |
| UnnamedSample_HQ_transcript/29995|m.9481 | UnnamedSample_HQ_transcript/29995 | Coverage 0.237 too low. | f0645f856d598278fcea6e19f100cb71 | 796 | Pfam | PF00989 | PAS fold | 80 | 139 | 8.1E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/29995|m.9481 | UnnamedSample_HQ_transcript/29995 | Coverage 0.237 too low. | f0645f856d598278fcea6e19f100cb71 | 796 | Pfam | PF08447 | PAS fold | 247 | 332 | 7.2E-15 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 4.0E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.2E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 8.5E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 8.5E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 2.0E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.7E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/10232|m.3899 | UnnamedSample_HQ_transcript/10232 | Coverage 0.949 too low. | 3b5e5f9adb6177678582d45770802909 | 893 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 3.2E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/75935|m.19007 | UnnamedSample_HQ_transcript/75935 | Coverage 0.897 too low. | 1b20ec50850ed01345e9ea051abd5339 | 351 | Pfam | PF04142 | Nucleotide-sugar transporter | 30 | 330 | 6.2E-39 | T | 22-09-2020 | IPR007271 | Nucleotide-sugar transporter |
| UnnamedSample_HQ_transcript/81768|m.19994 | UnnamedSample_HQ_transcript/81768 | Coverage 0.973 too low. | 1b20ec50850ed01345e9ea051abd5339 | 351 | Pfam | PF04142 | Nucleotide-sugar transporter | 30 | 330 | 6.2E-39 | T | 22-09-2020 | IPR007271 | Nucleotide-sugar transporter |
| UnnamedSample_HQ_transcript/60872|m.16233 | UnnamedSample_HQ_transcript/60872 | Coverage 0.050 too low. | 1b20ec50850ed01345e9ea051abd5339 | 351 | Pfam | PF04142 | Nucleotide-sugar transporter | 30 | 330 | 6.2E-39 | T | 22-09-2020 | IPR007271 | Nucleotide-sugar transporter |
| UnnamedSample_HQ_transcript/63768|m.16789 | UnnamedSample_HQ_transcript/63768 | Coverage 0.895 too low. | 1b20ec50850ed01345e9ea051abd5339 | 351 | Pfam | PF04142 | Nucleotide-sugar transporter | 30 | 330 | 6.2E-39 | T | 22-09-2020 | IPR007271 | Nucleotide-sugar transporter |
| UnnamedSample_HQ_transcript/59824|m.16024 | UnnamedSample_HQ_transcript/59824 | Coverage 0.482 too low. | 8ae5d0d52420574b396d8f01b14c12aa | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 127 | 509 | 1.1E-93 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/46380|m.13225 | UnnamedSample_HQ_transcript/46380 | Identity 0.752 too low. | 631cdcb402fb39ffb2337bd376def4d8 | 461 | Pfam | PF08777 | RNA binding motif | 346 | 432 | 3.7E-11 | T | 22-09-2020 | IPR014886 | La protein, RNA-binding domain |
| UnnamedSample_HQ_transcript/2838|m.1381 | UnnamedSample_HQ_transcript/2838 | Coverage 0.237 too low. | 442d4d5f120c6f9b3baa85c6d4dcea1c | 1108 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 834 | 1082 | 2.5E-74 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/2838|m.1381 | UnnamedSample_HQ_transcript/2838 | Coverage 0.237 too low. | 442d4d5f120c6f9b3baa85c6d4dcea1c | 1108 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 48 | 108 | 3.4E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/2838|m.1381 | UnnamedSample_HQ_transcript/2838 | Coverage 0.237 too low. | 442d4d5f120c6f9b3baa85c6d4dcea1c | 1108 | Pfam | PF13246 | Cation transport ATPase (P-type) | 497 | 587 | 3.9E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32250|m.10018 | UnnamedSample_HQ_transcript/32250 | Identity 0.950 too low. | 40bf2239a8ad6efff9dc2a23cc5ced34 | 203 | Pfam | PF05236 | Transcription initiation factor TFIID component TAF4 family | 2 | 199 | 2.5E-51 | T | 22-09-2020 | IPR007900 | Transcription initiation factor TFIID component TAF4 |
| UnnamedSample_HQ_transcript/31267|m.9778 | UnnamedSample_HQ_transcript/31267 | Coverage 0.194 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.8E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/31267|m.9778 | UnnamedSample_HQ_transcript/31267 | Coverage 0.194 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF19055 | ABC-2 type transporter | 236 | 303 | 1.2E-12 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/31267|m.9778 | UnnamedSample_HQ_transcript/31267 | Coverage 0.194 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF01061 | ABC-2 type transporter | 438 | 645 | 8.8E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/10151|m.3875 | UnnamedSample_HQ_transcript/10151 | Coverage 0.030 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.8E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/10151|m.3875 | UnnamedSample_HQ_transcript/10151 | Coverage 0.030 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF19055 | ABC-2 type transporter | 236 | 303 | 1.2E-12 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/10151|m.3875 | UnnamedSample_HQ_transcript/10151 | Coverage 0.030 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF01061 | ABC-2 type transporter | 438 | 645 | 8.8E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/15337|m.5506 | UnnamedSample_HQ_transcript/15337 | Coverage 0.115 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.8E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/15337|m.5506 | UnnamedSample_HQ_transcript/15337 | Coverage 0.115 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF19055 | ABC-2 type transporter | 236 | 303 | 1.2E-12 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/15337|m.5506 | UnnamedSample_HQ_transcript/15337 | Coverage 0.115 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF01061 | ABC-2 type transporter | 438 | 645 | 8.8E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/7020|m.2868 | UnnamedSample_HQ_transcript/7020 | Coverage 0.118 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.8E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/7020|m.2868 | UnnamedSample_HQ_transcript/7020 | Coverage 0.118 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF19055 | ABC-2 type transporter | 236 | 303 | 1.2E-12 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/7020|m.2868 | UnnamedSample_HQ_transcript/7020 | Coverage 0.118 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF01061 | ABC-2 type transporter | 438 | 645 | 8.8E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/7723|m.3096 | UnnamedSample_HQ_transcript/7723 | Coverage 0.095 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.8E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/7723|m.3096 | UnnamedSample_HQ_transcript/7723 | Coverage 0.095 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF19055 | ABC-2 type transporter | 236 | 303 | 1.2E-12 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/7723|m.3096 | UnnamedSample_HQ_transcript/7723 | Coverage 0.095 too low. | 997732c2a707af04dd7554777aa393b2 | 712 | Pfam | PF01061 | ABC-2 type transporter | 438 | 645 | 8.8E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/63597|m.16755 | UnnamedSample_HQ_transcript/63597 | Coverage 0.312 too low. | a3fc07a4f9cd7e1d2a8914d6107830d3 | 454 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/11751|m.4407 | UnnamedSample_HQ_transcript/11751 | Coverage 0.988 too low. | 0115f6cce9f1dc13e8bb5355674fb038 | 265 | Pfam | PF03054 | tRNA methyl transferase | 4 | 250 | 4.3E-93 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/53502|m.14740 | UnnamedSample_HQ_transcript/53502 | Coverage 0.224 too low. | 762ab744a2accf208f125af5d614f1a6 | 588 | Pfam | PF02845 | CUE domain | 339 | 377 | 4.1E-8 | T | 22-09-2020 | IPR003892 | Ubiquitin system component CUE |
| UnnamedSample_HQ_transcript/98364|m.22416 | UnnamedSample_HQ_transcript/98364 | Identity 0.359 too low. | 66205174e6a1724f3776aae7bb0df103 | 353 | Pfam | PF02142 | MGS-like domain | 16 | 129 | 3.7E-22 | T | 22-09-2020 | IPR011607 | Methylglyoxal synthase-like domain |
| UnnamedSample_HQ_transcript/98364|m.22416 | UnnamedSample_HQ_transcript/98364 | Identity 0.359 too low. | 66205174e6a1724f3776aae7bb0df103 | 353 | Pfam | PF01808 | AICARFT/IMPCHase bienzyme | 135 | 353 | 1.3E-60 | T | 22-09-2020 | IPR002695 | Bifunctional purine biosynthesis protein PurH-like |
| UnnamedSample_HQ_transcript/48356|m.13659 | UnnamedSample_HQ_transcript/48356 | Coverage 0.537 too low. | 83180e1d932d9367103908ddbc8bd958 | 410 | Pfam | PF07002 | Copine | 323 | 406 | 3.2E-29 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/48356|m.13659 | UnnamedSample_HQ_transcript/48356 | Coverage 0.537 too low. | 83180e1d932d9367103908ddbc8bd958 | 410 | Pfam | PF00168 | C2 domain | 20 | 118 | 6.5E-13 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/48356|m.13659 | UnnamedSample_HQ_transcript/48356 | Coverage 0.537 too low. | 83180e1d932d9367103908ddbc8bd958 | 410 | Pfam | PF00168 | C2 domain | 171 | 254 | 3.1E-4 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/73700|m.18598 | UnnamedSample_HQ_transcript/73700 | Coverage 0.397 too low. | e3ed67bf85044695311dc00a713ac027 | 336 | Pfam | PF08610 | Peroxisomal membrane protein (Pex16) | 13 | 328 | 5.1E-67 | T | 22-09-2020 | IPR013919 | Peroxisome membrane protein, Pex16 |
| UnnamedSample_HQ_transcript/81392|m.19943 | UnnamedSample_HQ_transcript/81392 | Coverage 0.429 too low. | e3ed67bf85044695311dc00a713ac027 | 336 | Pfam | PF08610 | Peroxisomal membrane protein (Pex16) | 13 | 328 | 5.1E-67 | T | 22-09-2020 | IPR013919 | Peroxisome membrane protein, Pex16 |
| UnnamedSample_HQ_transcript/100187|m.22671 | UnnamedSample_HQ_transcript/100187 | Coverage 0.365 too low. | e3ed67bf85044695311dc00a713ac027 | 336 | Pfam | PF08610 | Peroxisomal membrane protein (Pex16) | 13 | 328 | 5.1E-67 | T | 22-09-2020 | IPR013919 | Peroxisome membrane protein, Pex16 |
| UnnamedSample_HQ_transcript/83152|m.20221 | UnnamedSample_HQ_transcript/83152 | Identity 0.807 too low. | 9af8ce6e98a7998ba397515a6da59cac | 359 | Pfam | PF04193 | PQ loop repeat | 262 | 318 | 2.3E-17 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/83152|m.20221 | UnnamedSample_HQ_transcript/83152 | Identity 0.807 too low. | 9af8ce6e98a7998ba397515a6da59cac | 359 | Pfam | PF04193 | PQ loop repeat | 124 | 180 | 5.9E-19 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/77243|m.19249 | UnnamedSample_HQ_transcript/77243 | Identity 0.734 too low. | 9af8ce6e98a7998ba397515a6da59cac | 359 | Pfam | PF04193 | PQ loop repeat | 262 | 318 | 2.3E-17 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/77243|m.19249 | UnnamedSample_HQ_transcript/77243 | Identity 0.734 too low. | 9af8ce6e98a7998ba397515a6da59cac | 359 | Pfam | PF04193 | PQ loop repeat | 124 | 180 | 5.9E-19 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/98078|m.22378 | UnnamedSample_HQ_transcript/98078 | Coverage 0.989 too low. | ceba25ba833fa2b2c9f9e3f676a6c104 | 253 | Pfam | PF06984 | Mitochondrial 39-S ribosomal protein L47 (MRP-L47) | 38 | 123 | 2.0E-35 | T | 22-09-2020 | IPR010729 | Ribosomal protein L47, mitochondrial |
| UnnamedSample_HQ_transcript/37816|m.11349 | UnnamedSample_HQ_transcript/37816 | Coverage 0.986 too low. | badcc2dd3926834ae4771fb9c2d6cafa | 701 | Pfam | PF04515 | Plasma-membrane choline transporter | 316 | 671 | 1.7E-72 | T | 22-09-2020 | IPR007603 | Choline transporter-like |
| UnnamedSample_HQ_transcript/2573|m.1261 | UnnamedSample_HQ_transcript/2573 | Coverage 0.831 too low. | fbc8a5921fa0f14bf444acba6a95ccf4 | 880 | Pfam | PF17919 | RNase H-like domain found in reverse transcriptase | 811 | 880 | 4.5E-19 | T | 22-09-2020 | IPR041577 | Reverse transcriptase/retrotransposon-derived protein, RNase H-like domain |
| UnnamedSample_HQ_transcript/2573|m.1261 | UnnamedSample_HQ_transcript/2573 | Coverage 0.831 too low. | fbc8a5921fa0f14bf444acba6a95ccf4 | 880 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 613 | 748 | 1.5E-17 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/47441|m.13454 | UnnamedSample_HQ_transcript/47441 | Coverage 0.121 too low. | 481556d9c286b8525bd47e3b7bd82aef | 494 | Pfam | PF07690 | Major Facilitator Superfamily | 14 | 419 | 8.5E-42 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/49862|m.13990 | UnnamedSample_HQ_transcript/49862 | Coverage 0.150 too low. | 481556d9c286b8525bd47e3b7bd82aef | 494 | Pfam | PF07690 | Major Facilitator Superfamily | 14 | 419 | 8.5E-42 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/40099|m.11864 | UnnamedSample_HQ_transcript/40099 | Coverage 0.166 too low. | 481556d9c286b8525bd47e3b7bd82aef | 494 | Pfam | PF07690 | Major Facilitator Superfamily | 14 | 419 | 8.5E-42 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/45535|m.13043 | UnnamedSample_HQ_transcript/45535 | Coverage 0.205 too low. | 481556d9c286b8525bd47e3b7bd82aef | 494 | Pfam | PF07690 | Major Facilitator Superfamily | 14 | 419 | 8.5E-42 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/85988|m.20649 | UnnamedSample_HQ_transcript/85988 | Identity 0.633 too low. | 85e58c26f77e0d8a8ed6a2b82a98c8a7 | 349 | Pfam | PF01576 | Myosin tail | 2 | 310 | 1.1E-44 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/43003|m.12487 | UnnamedSample_HQ_transcript/43003 | Coverage 0.984 too low. | ce711efa8175ceaa43fc147d977c056c | 680 | Pfam | PF00226 | DnaJ domain | 620 | 659 | 3.1E-12 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/43003|m.12487 | UnnamedSample_HQ_transcript/43003 | Coverage 0.984 too low. | ce711efa8175ceaa43fc147d977c056c | 680 | Pfam | PF00012 | Hsp70 protein | 5 | 606 | 1.0E-221 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/64591|m.16960 | UnnamedSample_HQ_transcript/64591 | Coverage 0.465 too low. | 5446e9b81d9268ec2a0cf41fd6643c08 | 526 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 114 | 504 | 4.9E-103 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/11953|m.4484 | UnnamedSample_HQ_transcript/11953 | Unmapped. | 24ec5feaf35d1f6fd0f3ebbe917f85d6 | 1067 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1038 | 2.1E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/70456|m.18007 | UnnamedSample_HQ_transcript/70456 | Coverage 0.954 too low. | 96faf3ff0a5308585c89e8b131697b5a | 501 | Pfam | PF03165 | MH1 domain | 28 | 129 | 5.5E-20 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/77076|m.19211 | UnnamedSample_HQ_transcript/77076 | Coverage 0.805 too low. | ee6dcaa8c37551568207652d09f107f8 | 423 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/120012|m.24851 | UnnamedSample_HQ_transcript/120012 | Coverage 0.741 too low. | 269f945331496f7a64373b0131bd2951 | 177 | Pfam | PF00069 | Protein kinase domain | 2 | 176 | 1.4E-55 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/23741|m.7875 | UnnamedSample_HQ_transcript/23741 | Coverage 0.039 too low. | c9aabc8358bc405fe8e60ae9cdc7d8b1 | 705 | Pfam | PF02837 | Glycosyl hydrolases family 2, sugar binding domain | 78 | 148 | 8.3E-9 | T | 22-09-2020 | IPR006104 | Glycosyl hydrolases family 2, sugar binding domain |
| UnnamedSample_HQ_transcript/23741|m.7875 | UnnamedSample_HQ_transcript/23741 | Coverage 0.039 too low. | c9aabc8358bc405fe8e60ae9cdc7d8b1 | 705 | Pfam | PF00703 | Glycosyl hydrolases family 2 | 220 | 337 | 1.2E-7 | T | 22-09-2020 | IPR006102 | Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich |
| UnnamedSample_HQ_transcript/23741|m.7875 | UnnamedSample_HQ_transcript/23741 | Coverage 0.039 too low. | c9aabc8358bc405fe8e60ae9cdc7d8b1 | 705 | Pfam | PF02836 | Glycosyl hydrolases family 2, TIM barrel domain | 359 | 579 | 3.5E-7 | T | 22-09-2020 | IPR006103 | Glycoside hydrolase family 2, catalytic domain |
| UnnamedSample_HQ_transcript/16901|m.5971 | UnnamedSample_HQ_transcript/16901 | Coverage 0.025 too low. | a962d2a3fee594e83c05b6c1498c209b | 540 | Pfam | PF00069 | Protein kinase domain | 13 | 263 | 5.5E-69 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/12027|m.4505 | UnnamedSample_HQ_transcript/12027 | Coverage 0.113 too low. | a962d2a3fee594e83c05b6c1498c209b | 540 | Pfam | PF00069 | Protein kinase domain | 13 | 263 | 5.5E-69 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/15116|m.5431 | UnnamedSample_HQ_transcript/15116 | Coverage 0.059 too low. | a962d2a3fee594e83c05b6c1498c209b | 540 | Pfam | PF00069 | Protein kinase domain | 13 | 263 | 5.5E-69 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/26695|m.8649 | UnnamedSample_HQ_transcript/26695 | Coverage 0.146 too low. | a962d2a3fee594e83c05b6c1498c209b | 540 | Pfam | PF00069 | Protein kinase domain | 13 | 263 | 5.5E-69 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/47662|m.13504 | UnnamedSample_HQ_transcript/47662 | Coverage 0.170 too low. | a962d2a3fee594e83c05b6c1498c209b | 540 | Pfam | PF00069 | Protein kinase domain | 13 | 263 | 5.5E-69 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/5923|m.2514 | UnnamedSample_HQ_transcript/5923 | Coverage 0.384 too low. | f0267e3835b8d835553d2af370e3a1ce | 361 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 33 | 344 | 3.3E-34 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/19288|m.6662 | UnnamedSample_HQ_transcript/19288 | Coverage 0.973 too low. | c45a655fa34758a3337f7b7ee1bcd4f3 | 992 | Pfam | PF00168 | C2 domain | 11 | 104 | 4.8E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/19288|m.6662 | UnnamedSample_HQ_transcript/19288 | Coverage 0.973 too low. | c45a655fa34758a3337f7b7ee1bcd4f3 | 992 | Pfam | PF00168 | C2 domain | 839 | 941 | 2.2E-13 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/13503|m.4953 | UnnamedSample_HQ_transcript/13503 | Coverage 0.988 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00549 | CoA-ligase | 651 | 775 | 4.7E-17 | T | 22-09-2020 | IPR005811 | ATP-citrate lyase/succinyl-CoA ligase |
| UnnamedSample_HQ_transcript/13503|m.4953 | UnnamedSample_HQ_transcript/13503 | Coverage 0.988 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00285 | Citrate synthase, C-terminal domain | 875 | 1074 | 2.7E-19 | T | 22-09-2020 | IPR002020 | Citrate synthase |
| UnnamedSample_HQ_transcript/13503|m.4953 | UnnamedSample_HQ_transcript/13503 | Coverage 0.988 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF02629 | CoA binding domain | 486 | 591 | 1.1E-11 | T | 22-09-2020 | IPR003781 | CoA-binding |
| UnnamedSample_HQ_transcript/13503|m.4953 | UnnamedSample_HQ_transcript/13503 | Coverage 0.988 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF16114 | ATP citrate lyase citrate-binding | 242 | 419 | 1.5E-90 | T | 22-09-2020 | IPR032263 | ATP-citrate synthase, citrate-binding domain |
| UnnamedSample_HQ_transcript/13503|m.4953 | UnnamedSample_HQ_transcript/13503 | Coverage 0.988 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF08442 | ATP-grasp domain | 47 | 205 | 1.5E-9 | T | 22-09-2020 | IPR013650 | ATP-grasp fold, succinyl-CoA synthetase-type |
| UnnamedSample_HQ_transcript/15646|m.5599 | UnnamedSample_HQ_transcript/15646 | Coverage 0.972 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00549 | CoA-ligase | 651 | 775 | 4.7E-17 | T | 22-09-2020 | IPR005811 | ATP-citrate lyase/succinyl-CoA ligase |
| UnnamedSample_HQ_transcript/15646|m.5599 | UnnamedSample_HQ_transcript/15646 | Coverage 0.972 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00285 | Citrate synthase, C-terminal domain | 875 | 1074 | 2.7E-19 | T | 22-09-2020 | IPR002020 | Citrate synthase |
| UnnamedSample_HQ_transcript/15646|m.5599 | UnnamedSample_HQ_transcript/15646 | Coverage 0.972 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF02629 | CoA binding domain | 486 | 591 | 1.1E-11 | T | 22-09-2020 | IPR003781 | CoA-binding |
| UnnamedSample_HQ_transcript/15646|m.5599 | UnnamedSample_HQ_transcript/15646 | Coverage 0.972 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF16114 | ATP citrate lyase citrate-binding | 242 | 419 | 1.5E-90 | T | 22-09-2020 | IPR032263 | ATP-citrate synthase, citrate-binding domain |
| UnnamedSample_HQ_transcript/15646|m.5599 | UnnamedSample_HQ_transcript/15646 | Coverage 0.972 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF08442 | ATP-grasp domain | 47 | 205 | 1.5E-9 | T | 22-09-2020 | IPR013650 | ATP-grasp fold, succinyl-CoA synthetase-type |
| UnnamedSample_HQ_transcript/9239|m.3581 | UnnamedSample_HQ_transcript/9239 | Coverage 0.989 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00549 | CoA-ligase | 651 | 775 | 4.7E-17 | T | 22-09-2020 | IPR005811 | ATP-citrate lyase/succinyl-CoA ligase |
| UnnamedSample_HQ_transcript/9239|m.3581 | UnnamedSample_HQ_transcript/9239 | Coverage 0.989 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF00285 | Citrate synthase, C-terminal domain | 875 | 1074 | 2.7E-19 | T | 22-09-2020 | IPR002020 | Citrate synthase |
| UnnamedSample_HQ_transcript/9239|m.3581 | UnnamedSample_HQ_transcript/9239 | Coverage 0.989 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF02629 | CoA binding domain | 486 | 591 | 1.1E-11 | T | 22-09-2020 | IPR003781 | CoA-binding |
| UnnamedSample_HQ_transcript/9239|m.3581 | UnnamedSample_HQ_transcript/9239 | Coverage 0.989 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF16114 | ATP citrate lyase citrate-binding | 242 | 419 | 1.5E-90 | T | 22-09-2020 | IPR032263 | ATP-citrate synthase, citrate-binding domain |
| UnnamedSample_HQ_transcript/9239|m.3581 | UnnamedSample_HQ_transcript/9239 | Coverage 0.989 too low. | a4f477aaeb6ed4d4dc008b76a8c52012 | 1091 | Pfam | PF08442 | ATP-grasp domain | 47 | 205 | 1.5E-9 | T | 22-09-2020 | IPR013650 | ATP-grasp fold, succinyl-CoA synthetase-type |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||